SPC Financial Inc. Lowers Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPC Financial Inc. trimmed its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,781 shares of the exchange traded fund’s stock after selling 1,730 shares during the quarter. SPC Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $431,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Hartline Investment Corp grew its stake in SPDR S&P Biotech ETF by 2.0% during the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after buying an additional 106 shares during the period. Addison Advisors LLC grew its stake in SPDR S&P Biotech ETF by 27.4% during the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after buying an additional 115 shares during the period. Signature Estate & Investment Advisors LLC grew its stake in SPDR S&P Biotech ETF by 5.7% during the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after buying an additional 125 shares during the period. Graypoint LLC grew its stake in SPDR S&P Biotech ETF by 5.6% during the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after buying an additional 146 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in SPDR S&P Biotech ETF by 0.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after buying an additional 148 shares during the period.

SPDR S&P Biotech ETF Stock Up 2.0 %

XBI opened at $87.82 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The company has a 50 day moving average of $90.68 and a two-hundred day moving average of $95.52. The company has a market cap of $5.79 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.